AdnaGen AG Product Pipeline Analysis

SUMMARY

AdnaGen AG Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a AdnaGen AG's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Industry Outlook -- In Vitro Diagnostics 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
7 Recent Developments 12
7.1 Product News 12
7.1.1 May 07, 2008: AdnaGen Announces The Submission Of A Request For A Pre-IDE Determination Meeting With FDA For AdnaGen´s AdnaTest Breast Cancer For The Detection Of Circulating Breast Tumor Cells 12
7.1.2 Oct 11, 2007: AdnaGen Signs Exclusive Agreement With Innogenetics To Develop And Commercialize New Multiplex Oncology Tests 12
8 AdnaGen AG Pipeline Products 13
8.1 AdnaGen AG Product Pipeline Analysis 13
8.1.1 AdnaGen AG Pipeline Products By Equipment Type 13
8.1.2 AdnaGen AG Pipeline Products By Development Stage 14
8.1.3 AdnaGen AG Pipeline Products By Therapy Area 15
8.1.4 AdnaGen AG Pipeline Products By Clinical Trials 15
8.1.5 AdnaGen AG Pipeline Products By News Summary 15
8.2 New multiplex oncology tests 15
8.2.1 Product Description 15
8.2.2 Product Status 16
8.2.3 Product Milestone 16
8.3 AdnaTest ColonCancer 16
8.3.1 Product Description 16
8.3.2 Product Status 17
8.3.3 Clinical Trials 17
8.3.4 Product Milestone 18
8.4 AdnaTest BreastCancer 18
8.4.1 Product Description 19
8.4.2 Product Status 19
8.4.3 Clinical Trials 19
8.4.4 Product Milestone 20
8.5 AdnaTest OvarianCancer 20
8.5.1 Product Description 21
8.5.2 Product Status 21
8.5.3 Product Patent Details 21
9 Appendix 22
9.1 Methodology 22
9.1.1 Coverage 22
9.1.2 Secondary Research 23
9.1.3 Primary Research 23
9.1.4 Expert Panel Validation 24
9.2 Contact Us 24
9.3 About Global Markets Direct 24
9.4 Disclaimer 24

1.1 List Of Tables
Table 1: AdnaGen AG,Key Facts 7
Table 2: AdnaGen AG, Key Employees, 10
Table 3: AdnaGen AG Pipeline Products by Equipment Type 13
Table 4: AdnaGen AG Pipeline Products By Development Stage 14
Table 5: AdnaGen AG Pipeline Products By Therapy Area 15
Table 6: AdnaGen AG Pipeline Products By Clinical Trials 15
Table 7: AdnaGen AG Pipeline Products By News Summaries 15

1.2 List of Figures
Figure 1: AdnaGen AG Pipeline Products By Development Stage 14
Figure 2: Global Markets Direct Methodology 22